80/100 A · Critical risk
1 serious risk flag found Indicative TraceComp estimate from public sources — an automated indicator, not a credit decision, a completed due-diligence check, or a guarantee. Verify against the official register.
  • 🔴 Insolvency / collective proceedings on file (12)

Think this is wrong? This is an automated estimate — request a human review or correction.

DXO LABS

Active Simplified joint-stock company (SAS) Publishing Active for 23 years

Simplified joint-stock company (SAS) · RC 444777577 · Active since 2003

A

Overview

DXO LABS is a simplified joint-stock company (sas) registered in France, since 2003. The company operates in the publishing sector. Its TraceComp score of 80 (A) indicates solid fundamentals and low apparent risk. With 23 years of operations, the company has an established track record in its market.

Company Information

Registration Number
444777577
Legal Form
Simplified joint-stock company (SAS)
Registered
2003-01-02

Insolvency & Collective Proceedings

12 insolvency / collective-proceedings notices on file — most recent published 2021-02-16. A material adverse finding for counterparty and credit risk.

Insolvency notice types, titles, publication dates and official Gazette sources.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

EU Funding

EU-funded innovation. Participated in 1 EU research project, receiving €262,876 in EU contributions (CORDIS — Horizon Europe / Horizon 2020).

Source: CORDIS (EU Open Data, CC-BY). Cumulative EC contribution across the company’s projects.

Patent Portfolio

Active patent holder. 21 patents · 20 active · 21 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • No financial filings on record — score derives from registry signals and sector context

Data Sources & Freshness

Data sourced from: bulk register.